The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Novartis; Pfizer; Sanofi; Viatris
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD Oncology; Pfizer
The impact of baseline peripheral cytokines on survival in metastatic clear cell renal cell carcinoma (RCC) treated with nivolumab: NIVOREN GETUG-AFU 26 Translational study.
 
Lucia Carril
No Relationships to Disclose
 
Marie Naigeon
No Relationships to Disclose
 
Cécile Dalban
No Relationships to Disclose
 
Aude Desnoyer
No Relationships to Disclose
 
Nathalie Rioux-Leclercq
No Relationships to Disclose
 
Catherine Sautes-Fridman
No Relationships to Disclose
 
Maxime Meylan
No Relationships to Disclose
 
Yann-Alexandre Vano
No Relationships to Disclose
 
Benoit Beusenlick
No Relationships to Disclose
 
Salem Chouaib
No Relationships to Disclose
 
Caroline de Oliveira
No Relationships to Disclose
 
Florence Tantot
No Relationships to Disclose
 
Bernard Escudier
Honoraria - Bristol-Myers Squibb; Ipsen; Oncorena; Pfizer
Consulting or Advisory Role - AVEO; Bristol-Myers Squibb; Ipsen; Oncorena; Pfizer
Research Funding - BMS France (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Ipsen; MSD
 
Laurence Albiges
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Exelixis (Inst); Ipsen (Inst); Janssen (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Peloton therapeutics (Inst); Pfizer (Inst); Roche (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Nathalie Chaput
No Relationships to Disclose